Colin Barrie
Livingston, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Multidisciplinary Prehabilitation Reduces Hospitalization Time and Suggests Improved Survival in Patients with Radiologically Diagnosed Lung Cancer.
Journal: Cancers
Published: June 26, 2025
Early prehabilitation reduces admissions and time in hospital in patients with newly diagnosed lung cancer.
Journal: BMJ supportive & palliative care
Published: March 07, 2024
Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer.
Journal: Cancers
Published: October 12, 2023
Prehabilitation Reduces Hospital Admissions for Patients With Advanced Lung Cancer.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: September 21, 2023
Early prehabilitation in suspected locally advanced and metastatic lung cancer.
Journal: BMJ supportive & palliative care
Published: May 01, 2023
Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 23, 2023
Comment on: Prehabilitation and Rehabilitation for Patients with Lung Cancer: A Review of Where We are Today.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: January 30, 2023
Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer.
Journal: ESMO open
Published: November 08, 2021
Challenging presentations of germ cell tumours in routine clinical practice.
Journal: The journal of the Royal College of Physicians of Edinburgh
Published: April 20, 2021
Last Updated: 09/26/2026